Fidelity Investments’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.8K | Buy |
12,681
+1,811
| +17% | +$3.82K | ﹤0.01% | 4171 |
|
|
2025
Q1 | $13.3K | Buy |
10,870
+9,049
| +497% | +$11K | ﹤0.01% | 4388 |
|
|
2024
Q4 | $2.35K | Buy |
1,821
+1,639
| +901% | +$2.11K | ﹤0.01% | 4795 |
|
|
2024
Q3 | $501 | Buy |
+182
| New | +$501 | ﹤0.01% | 4962 |
|
|
2023
Q2 | – | Sell |
-3,200
| Closed | -$6.72K | – | 5459 |
|
|
2023
Q1 | $6.72K | Buy |
+3,200
| New | +$6.72K | ﹤0.01% | 4285 |
|
|
2022
Q3 | – | Sell |
-4,000
| Closed | -$5K | – | 5074 |
|
|
2022
Q2 | $5K | Buy |
4,000
+1,975
| +98% | +$2.47K | ﹤0.01% | 4310 |
|
|
2022
Q1 | $3K | Buy |
2,025
+1,980
| +4,400% | +$2.93K | ﹤0.01% | 4562 |
|
|
2021
Q4 | $0 | Hold |
45
| – | – | ﹤0.01% | 4567 |
|
|
2021
Q3 | $0 | Buy |
45
+44
| +4,400% | – | ﹤0.01% | 4602 |
|
|
2021
Q2 | $0 | Sell |
1
-1,499
| -100% | – | ﹤0.01% | 4478 |
|
|
2021
Q1 | $3K | Buy |
+1,500
| New | +$3K | ﹤0.01% | 3636 |
|
|
2019
Q4 | – | Sell |
-16
| Closed | – | – | 3951 |
|
|
2019
Q3 | $0 | Hold |
16
| – | – | ﹤0.01% | 3935 |
|
|
2019
Q2 | $0 | Buy |
+16
| New | – | ﹤0.01% | 3890 |
|
|
2019
Q1 | – | Sell |
-800
| Closed | -$3K | – | 3815 |
|
|
2018
Q4 | $3K | Hold |
800
| – | – | ﹤0.01% | 3270 |
|
|
2018
Q3 | $5K | Buy |
+800
| New | +$5K | ﹤0.01% | 3252 |
|